Free US stock ESG scoring and sustainability analysis for responsible investing considerations. We evaluate environmental, social, and governance factors that increasingly impact long-term company performance.
Celldex Therapeutics Inc. (CLDX) is trading at $31.35 as of 2026-04-07, posting a modest 0.06% dip in today’s session amid flat broader market trading for healthcare stocks. This analysis outlines key technical levels, prevailing market context, and potential short-term price scenarios for the clinical-stage biotech stock, with no recent earnings data available for the company as of publication. There are no confirmed, publicly disclosed pipeline or regulatory events scheduled for the near term
What are analysts saying about Celldex (CLDX) Stock | Price at $31.35, Down 0.06% - Open Stock Picks
CLDX - Stock Analysis
3188 Comments
640 Likes
1
Claudetta
Influential Reader
2 hours ago
I’m emotionally invested and I don’t know why.
👍 65
Reply
2
Tondalaya
Power User
5 hours ago
Get expert US stock recommendations backed by technical analysis, market trends, and institutional activity to maximize returns while minimizing downside risk. Our team of experienced analysts constantly monitors market movements to identify the most promising opportunities for your portfolio.
👍 107
Reply
3
Averee
Daily Reader
1 day ago
Balanced approach, easy to digest key information.
👍 127
Reply
4
Albaraa
Active Contributor
1 day ago
Join a US stock community sharing real-time updates, expert analysis, and strategies designed to minimize risks and maximize long-term returns. Our community members benefit from collective wisdom and shared experiences that accelerate their investment success.
👍 125
Reply
5
Adaiah
Power User
2 days ago
Offers perspective on market movements that isn’t obvious at first glance.
👍 70
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.